U.S. STOCKS ON THE MOVE-Gamestop, Crypto stocks, Tesla, Harley-Davidson
XBiotech: Rises after FDA gives nod to conduct studies for cancer drug
Brief: Xbiotech Says FDA Has Granted Permission To Commence Clinical Trials With Its Novel Drug Candidate For Treating Patients With Pancreatic Cancer
U.S. STOCKS ON THE MOVE-United Airlines, Alcoa, Travelers, Under Armour, ADiTx
U.S. STOCKS ON THE MOVE-Under Armour, Snap, Travelers, Alcoa, United Airlines
Brief: XBiotech Candidate True Human COVID-19 Therapy Found To Target Highly Infectious Emerging Strain
XBiotech's COVID-19 therapy shows promise against virus variant, shares rise
XBiotech: Rises on positive data from COVID-19 antibody study
Brief: Xbiotech Data Shows Effective Anti-Virus Activity For True Human Antibodies In Its Candidate Influenza-Covid-19 Therapeutic Cocktail
XBiotech: Up on plans to develop drug for combined COVID-19, flu infections
Infections
Plasma therapy developers jump as U.S. authorizes plasma treatment for COVID-19
XBiotech: Jumps as U.S. FDA move clears way for COVID-19 plasma test
Brief: Xbiotech-Developed Covid-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization
Brief: Xbiotech Discovers Covid-19 Candidate Therapy
XBiotech: Jumps after co identifies antibodies for potential COVID-19 therapy
Brief: XBiotech Achieves Milestone For Production Of Its New Potential Blockbuster Anti-Il-1⍺ Therapy
Brief: XBiotech Announces Discovery That Blocking Interleukin-1A Reduces Brain Injury And Neurological Deficit After Stroke
Brief: Xbiotech - Announced That Human Immune Donors Have Been Identified That Can Support Co's Development Of True Human Antibody Therapy For Covid-19